Cancer Colorectal Now Leading Cause of Death Under 50
A new analysis from the American Cancer Society finds colorectal cancer is now the leading cause of cancer death in the United States for people under 50, a shift that moved the disease from the fifth to the first leading cause since the 1990s. The finding puts cancer colorectal screening and symptom awareness into sharper focus for younger adults and has prompted experts to urge anyone with rectal bleeding lasting more than a couple of weeks to see a doctor.
American Cancer Society analysis finds
The American Cancer Society analysis shows colorectal cancer has climbed to the top cause of cancer death among people under 50, while for people over age 65 the disease is continuing to decline rapidly by more than two percent a year. The analysis also finds that around three quarters of people under 50 already have advanced colorectal cancer when they are diagnosed, because they have not been screened earlier and often dismiss early signs. The figures point to a clear generational shift in burden: younger cohorts now carry higher risk even as incidence falls in older Americans.
Cancer Colorectal Rebecca Siegel urges
Rebecca Siegel, the epidemiologist and senior director of cancer surveillance research who led the analysis, urges anyone experiencing rectal bleeding for more than a couple of weeks to see their doctor immediately and notes that many people assume haemorrhoids when they see blood in stool. Siegel highlighted stool tests such as Cologuard and the FIT test as reasonable options for people without symptoms who want to screen before getting a colonoscopy. The pattern suggests that widening use of noninvasive screening could catch more early-stage disease among younger adults who are reluctant to undergo colonoscopy right away.
Becca Lynch diagnosis and symptoms
Becca Lynch, a 29-year-old who works in cyber security in Denver, Colorado, was diagnosed last year with stage 3B colon cancer after months of symptoms she initially dismissed as stress. Lynch described pencil-thin bowel movements, needing to go five or six times a day, and eventually seeing thick, dark blood with each movement; she delayed a colonoscopy for several months and sought care only after seeing an Instagram video by Cass Costley, who later died of the disease. Lynch’s case illustrates how early warning signs in younger adults can be overlooked and how delays in evaluation contribute to the high proportion of advanced-stage diagnoses.
Doctors will need to adapt clinical practice for younger patients, Siegel says, because treatment discussions must cover fertility and sexual function in ways that historically have not been part of care for older cohorts. Siegel pointed out that clinicians are used to treating people in their 70s who are not as concerned about fertility, and surveys report that young survivors often learn they cannot have children only after treatment is complete. The detail underscores a practical consequence: clinicians should discuss options to preserve fertility and sexual function before treatment begins.
Experts are not yet sure why rates have risen among younger people; Siegel called the pattern an example of the “birth cohort effect, ” noting that people born after the 1950s face heightened risk and that the signal points to some exposure or risk factor specific to those cohorts. If the birth cohort effect holds, the data suggests the key drivers occurred for people born after the 1950s and that identifying that exposure will be essential to reversing the trend.
